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What is already known about this subject? 
• Traits associated with adiposity such as body mass index and visceral adiposity are 
highly heritable, with genetics accounting for ~70% of the population variance. 
• Although many genes have been identified for adiposity traits, a small proportion of the 
heritable variance has been identified, indicating a critical need to identify the remaining 
genes. 
• Outbred rodent models enable rapid fine-mapping of genetic loci involved in complex 
traits to only a few Megabases, and may prove useful for uncovering some of the missing 
heritability for adiposity traits. 
What this study adds. 
• Similar to humans, we show that visceral adiposity is highly correlated with traits of 
metabolic health in outbred heterogeneous stock (HS) rats, demonstrating that this is an 
excellent model to study the underlying genetics of adiposity. 
• Using HS rats, we identify two quantitative trait loci (QTL) for visceral fat pad weight 
and one for body weight.  Linkage disequilibrium-based intervals for these loci are 
relatively small: 6.14, 1.19, and 3.35 Mb, respectively. 
• We identify candidate genes within each QTL, and likely causal variants within visceral 
fat pad loci.  Genes identified include Adcy3, Krtcap3, Slc30a3, Prlhr and Grid 2.  Likely 
causal variants are identified in Adcy3 and Prlhr, genes identified in the QTL for visceral 




Objective: Obesity is a major risk factor for multiple diseases and is in part heritable, yet the 
majority of causative genetic variants that drive excessive adiposity remain unknown.  Here, we 
used outbred heterogeneous stock (HS) rats in controlled environmental conditions to fine-map 
novel genetic modifiers of adiposity.   
Methods: Body weight and visceral fat pad weights were measured in male HS rats that were 
also genotyped genome-wide.  Quantitative trait loci (QTL) were identified by genome-wide 
association of imputed single nucleotide polymorphism (SNP) genotypes using a linear mixed 
effect model that accounts for unequal relatedness between the HS rats.  Candidate genes were 
assessed by protein modeling and mediation analysis of expression for coding and noncoding 
variants, respectively.   
Results:  HS rats exhibited large variation in adiposity traits, which were highly heritable and 
correlated with metabolic health.  Fine-mapping of fat pad weight and body weight revealed 
three QTL and prioritized five candidate genes.  Fat pad weight was associated with missense 
SNPs in Adcy3 and Prlhr and altered expression of Krtcap3 and Slc30a3, whereas Grid2 was 
identified as a candidate within the body weight locus.    
Conclusions: These data demonstrate the power of HS rats for identification of known and novel 








Obesity and overweight are major risk factors for multiple cardiovascular and metabolic diseases 
[1].  Of particular importance is visceral, or abdominal, adipose tissue, which is strongly 
predictive of metabolic health [2].  Multiple environmental (e.g., lifestyle) and genetic factors 
contribute to obesity with genetics accounting for up to 70% of the population variance for 
human body mass index (BMI) and obesity [3] and visceral adiposity [4].  To date, human 
genome-wide association studies have identified many genes for anthropomorphic traits [5-8], 
but these genes explain only a small proportion of the heritable variation [5], indicating many 
genes are yet unidentified.  Identification of additional genes is particularly important because 
there has been a steady increase in prevalence of overweight and obesity since the 1970’s [1], 
with over one third of adults and almost one fifth of all children in the United States being 
classified as obese [9].    
 
One strategy for identifying the heritable modifiers of obesity is to control for exogenous 
environmental factors using experimental genetic mapping strategies such as the outbred 
heterogeneous stock (HS) rats.  HS rats descend from eight inbred founder strains and have been 
out-bred for over 70 generations, such that the fine recombination block structure allows genetic 
mapping to identify regions that are only a few Mb [10].  In previous work, we used HS rats to 
fine-map a single region on rat chromosome 1 previously identified for glucose and insulin traits 
[11, 12], and identified Tpcn2 as a likely causal gene at this locus [13].  Here, we demonstrate 
that HS rats vary for adiposity traits including body weight and visceral fat pad weight, and that 
these measures correlate with metabolic health.  We then detect and fine-map QTL for these 




Methods and Procedures 
Animals 
Heterogeneous stock colony: The NMcwi:HS colony, hereafter referred to as HS, was initiated 
by the NIH in 1984 using the following eight inbred founder strains: ACI/N, BN/SsN, BUF/N, 
F344/N, M520/N, MR/N, WKY/N  and WN/N  [14].  This colony has been maintained at the 
Medical College of Wisconsin since 2006 and has been through over 70 generations of breeding.  
Rats were given ad libitum access to Teklad 5010 diet (Harlan Laboratories).  Additional 
housing conditions are detailed in Supplementary Methods. 
 
Founding inbred sub-strains: Other than M520/N (now maintained at MCW), phenotyping of 
the founders was conducted in the following sub-strains (abbreviated names to be used 
throughout manuscript in parentheses): ACI/Eur or ACI/Seg (ACI), BN/SsnHsd (BN), 




We measured body weight at 16 weeks of age in 989 male HS rats.  Rats underwent an intra-
peritoneal glucose tolerance test (IPGTT) as described previously [11, 12].  We used the 
Ascensia Elite system for reading blood glucose values (Bayer, Elkhart, IN).  Plasma insulin 
levels were determined using an ultrasensitive ELISA kit (Alpco Diagnostics, Salem, NH).  The 
following metabolic measures were calculated: area under the curve for glucose (glucose_AUC) 
and insulin (insulin_AUC) during the IPGTT, the quantitative insulin sensitivity check 
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(QUICKI) as a measure of insulin sensitivity, and the insulinogenic index (IGI) as a measure of 
beta cell sensitivity to glucose [12].  
 
Inbreds and 743 HS rats were euthanized after an overnight fast at 17 weeks of age.  Body 
weight and two measures of body length (from nose to base of the tail and from nose to end of 
tail) were collected, allowing us to calculate two measures of body mass index: BMI_Tail_Base 
and BMI_Tail_End.  BMI was calculated as: (body weight/body length2)x10.  Rats were 
euthanized by decapitation and trunk blood was collected.  Fasting cholesterol and triglycerides 
were determined from fasting serum on an ACE Alera autoanalyzer using an enzymatic method 
for detection.  Several tissues were dissected and weighed including retroperitoneal and 
epididymal visceral fat pads, hereafter referred to as RetroFat and EpiFat, respectively.  Liver 
and adipose tissues were snap-frozen in liquid nitrogen for subsequent expression analysis.  All 
protocols were approved by the IACUC committee at MCW.  Phenotyping data have been 
deposited in RGD (www.rgd.mcw.edu). 
 
Genotyping 
We extracted DNA from tail tissue from HS and the original eight inbred founder strains (tissue 
obtained from the NIH) using either the Qiagen DNeasy kit (Valencia, CA) or a phenol-
chloroform extraction.  Founder and HS rats were genotyped using the Affymetrix GeneChip 
Targeted Genotyping technology on a custom 10K SNP array panel as previously described [15], 
with marker locations based on rat genome assembly 6.0.  147 samples were genotyped by the 
Vanderbilt Microarray Shared Resource center at Vanderbilt University in Tennessee (currently 
VANTAGE: http://www.vmsr.edu) and the remaining 842 by HudsonAlpha Institute 
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(http://hudsonalpha.org).   From the 10,846 SNPs on the array, 8,218 were informative and 
produced reliable genotypes in the HS rats.  From these final informative markers, the average 
SNP spacing was 284 Kb, with an average heterozygosity of 25.68%. Principle Component 
Analysis was used to confirm there were no systematic genotyping differences between the two 
centers (Figure S1).    
 
RNAseq 
RNA was extracted from liver of 398 HS rats using Trizol.  Illumina kits were used to create 
library preps and RNA-seq was run on the Illumina HiSeq 2500. RSEM and Bowtie were used to 
align reads and compute transcript level expression abundance (Supplementary Methods).   
  
Statistical Analysis 
Estimating heritability of adiposity traits. Narrow-sense heritability was estimated for each 
transformed phenotype using a Bayesian linear mixed model (LMM) implemented in INLA [16, 
17]. The LMM included fixed effects representing time food deprived, order of tissue harvest, 
and dissector (notably, dissector significantly affected EpiFat and BMI_Tail_Base), and a 
random “polygenic” effect, which represented the effect of overall relatedness (calculated using 
[18]). Heritability, ℎ", was defined as the proportion of variance attributed to polygenic effects 
vs residual noise (Supplemental Methods). 
 
Genome-wide association.  QTL were identified by genome-wide association of imputed allele 
dosages of genotyped SNPs. A hidden Markov model [19] was used to infer each HS rat’s 
haplotype mosaic and thereby obtain robust estimates of each SNP’s genotype. Association tests 
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were then performed, SNP-by-SNP, on each trait using a frequentist version of the LMM 
described for estimating heritability but with an added SNP effect term. Tests of the SNP effect 
yielded p-values that are here reported as negative log to the base 10, or “logP”. Genome-wide 
significance thresholds for logP scores were estimated by parametric bootstrap samples from the 
fitted null [11, 20].  Linkage Disequilibrium (LD) intervals for the detected QTL were defined by 
including neighboring markers that met a set level of LD, measured with the squared correlation 
coefficient r2; we used r2=0.5 to define intervals based on the plots of the SNP associations 
overlaid with LD information (Supplemental Methods). 
 
Fine-mapping and haplotype effect estimation at detected QTL. SNP variants within the LD 
interval were prioritized used the multi-SNP method LLARRMA-dawg [21], which calculates 
for each SNP a resample model inclusion probability (RMIP):  SNPs with high RMIPs represent 
strong, independent signals, and the existence of multiple SNPs with a high RMIP is consistent 
with the presence of multiple independent signals. To characterize each QTL signal, we used the 
Diploffect model [22], which estimates the relative contributions of alternate founder haplotypes 
(Supplemental Methods). 
 
Candidate gene identification.  Two parallel approaches were used: 1) bioinformatic analysis and 
protein modeling of known sequence variants; and, 2) mediation analysis of expression levels. 
For (1), we used HS founder sequence (www.rgd.mcw.edu; genome build Rn6) to identify 
highly conserved, non-synonymous coding variants within each QTL that were predicted to be 
damaging by Polyphen (http://genetics.bwh.harvard.edu/pph/) and/or SIFT, focusing on variants 
in founder strains that showed haplotype effects at the locus.  Variants were confirmed using 
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Sanger sequencing and then analyzed in the Sequence-to-Structure-to-Function analysis as 
previously described [23].  Briefly, proteins were assessed with codon selection analysis of 
multiple species open reading frames, inspected for linear motif impact near variants of interest, 
and modeled with I-TASSER [24] and YASARA [25].  Models were then assessed for likely 
impact on protein folding and/or function based on model confidence, phylogenetic sequence 
alignment, conservation, and whether or not the variant altered structural packing, molecular 
dynamic simulations, binding partners, linear motifs or post-translational modifications. For (2), 
transcript abundance levels of genes within HS liver were evaluated as potential causal mediators 
of the physiological QTL through mediation analysis [26] (Supplementary Methods). 
 
 Results 
HS founder strains exhibit large variation in adiposity traits 
All phenotypes were rank-inverse normal transformed except EpiFat, which instead was log 
transformed based on the Box-Cox procedure.  All traits differed significantly between the 
inbred founder strains: body weight (F5, 76 = 15.492, p = 1.74e-10), BMI_Tail_End (F5, 73 = 
25.024, p = 1.34e-14), BMI_Tail_Base (F5, 73 = 9.683, p = 4.02e-7), EpiFat (F5, 78 = 69.541, p < 
2.2e-16) and RetroFat (F5, 78 = 38.157, p < 2.2e-16; Figure 1).  The BUF inbred strain had 
significantly more EpiFat mass (Tukey-Kramer p < 0.05) and BMI_Tail_End (Tukey-Kramer p 
< 0.05) relative to all other strains.  BUF also had significantly more RetroFat mass compared to 
all strains (Tukey-Kramer p < 0.001) except F344 (Tukey-Kramer p = 0.06175), higher body 
weight relative to ACI, BN, and M520 (Tukey-Kramer p < 0.01), and higher BMI_Tail_Base 
than ACI and M520 (Tukey-Kramer p < 0.05).  ACI, BN and M520 were the lightest strains, 
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with BN and M520 showing significantly lighter EpiFat (Tukey-Kramer p < 1e-5) and RetroFat 
(Tukey-Kramer p < 0.001) relative to other strains.   
 
Adiposity traits are highly correlated with measures of metabolic health in HS rats 
Variation between the founder strains is represented within the HS colony (Figure 1).  Adiposity 
measures were highly correlated with several measures of metabolic health (Table 1, Figure 2).  
EpiFat significantly correlated with every measure of metabolic health and RetroFat correlated 
with all but fasting glucose.  Body weight significantly correlated with all measures except 
fasting triglycerides.  BMI_Tail_End significantly correlated with fasting total cholesterol, 
fasting tricglycerides, glucose AUC, insulin AUC, and IGI, whereas BMI_Tail_Base did not 
significantly correlate with any of the measures of metabolic health. 
 
Adiposity traits are highly heritable 
Adiposity traits were highly heritable in HS rats: body weight (posterior mode of ℎ" = 75.3%; 
95% highest posterior density interval = 67.0-81.7%), EpiFat (54.1%; 40.1-66.0%), RetroFat 
(53.9%; 39.7-66.7%), BMI_Tail_End (45.0%; 32.3%-57.2%) and BMI_Tail_Base (25.4%; 13.6-
41.8%). 
 
RetroFat QTL on chromosomes 1 and 6  
Two 90% significant QTL were identified for RetroFat, a QTL on rat chromosome 6: 22.79-
28.93 Mb (6.14 Mb, -logP = 4.73) and a QTL on chromosome 1: 280.63 – 281.82 Mb (1.19 Mb, 
-logP = 4.69; Figure 3ABC, 6ABC).  The LLARRMA-dawg multi-SNP fine-mapping analysis 
narrowed the most likely region of the broader chromosome 6 QTL to 1.46 Mb region (27.17 – 
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28.63 Mb; Figure S2) narrowing the number of the genes from 130 to 30 (Table S1, Figure S3). 
Estimating founder haplotype effects at the chromosome 6 QTL gave an effect size (posterior 
median) of 11.05% and showed that at this locus, decreased fat pad weight is associated with the 
WKY haplotype (Figure 3D).  For the chromosome 1 QTL the effect size was 13.33%, with 
increased fat pad weight associated with BUF, MR and WKY haplotypes (Figure 6D).  
 
Identification of Adcy3, Krtcap3, Slc30a3 within the chromosome 6 Retrofat QTL 
Within the chromosome 6 RetroFat QTL, bioinformatic analysis revealed only one gene, Adcy3, 
that had a highly conserved, potentially damaging, non-synonymous variant in the WKY rat, the 
founder haplotype associated with decreased Retrofat at this locus.  Adcy3 also falls within the 
fine-mapped support interval of the QTL (Figure 3C).  The WKY founder strain harbors a C at 
position 28,572,363 bp within Adcy3 while all other strains harbor a T, resulting in a leucine-to-
proline substitution at amino acid 121.  Based on DNA information from 86 nucleotide 
sequences for ADCY3, this variant is highly conserved with evidence for selective pressure.  
Protein modeling indicated that amino acid 121 is located within the first transmembrane region, 
with a proline likely causing a bend in the helix and thus altered transmembrane packing (Figure 
3E).   
 
Since fine-mapping supported multiple independent signals at the QTL, we investigated potential 
mediators among the cis-expressed genes. Mediation analysis identified six potential mediators, 
all driven by the WKY haplotype (Figure 4; Tables S4 and S5), suggesting that multiple genes 
may influence RetroFat at this locus. Two in particular were strongly supported:  Krtcap3 as a 
full mediator and Slc30a3 as a partial mediator, remaining significant after controlling for 
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Krtcap3. Under the proposed model (Figure 5), the WKY haplotype increases expression of 
Krtcap3, which is itself negatively correlated with RetroFat (Figure S4), and thus the causal path 
is consistent with the negative WKY effect on RetroFat at the locus; meanwhile, WKY decreases 
expression of Slc30a3, which is also negatively correlated RetroFat, suggesting Slc30a3 is a 
suppressor of the QTL/Krtcap3 effect. 
 
Identification of Prlhr within the chromosome 1 RetroFat QTL 
Within the chromosome 1 RetroFat QTL, there are 15 genes, ten of which are uncharacterized 
(Figure 6BC, Table S2).  One gene, Prlhr, contains a non-synonymous variant in the BUF and 
WKY founder strains, two founder haplotypes associated with an increase fat pad weight at this 
locus.  The variant falls within the start codon, changing methionine to isoleucine.  The next 
methionine falls at amino acid 65, such that the conserved N-terminal region and half of 
transmembrane helix 1 would be deleted with the variant (Figure 4E, 
https://youtu.be/vRTIkITXRbw). A molecular dynamic simulation of the PRLHR protein with 
and without the first 64 amino acids showed strong changes to the entire GPCR transmembrane 
region.  Prlhr is expressed mainly in adrenal and brain such that expression levels could not be 
determined in liver tissue.  None of the liver-expressed genes local to the QTL map as cis-eQTL, 
thus Prlhr remains the strongest candidate within this region. 
 
Body weight QTL on chromosome 4 and identification of Grid2 
A 95% significant QTL for body weight was also detected on rat chromosome 4: 91.35Mb to 
94.7Mb (3.35 Mb, -logP = 5.32) (Figure 7ABC). At this locus, whose effect size was 12.33%, 
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decreases in body weight were associated with ACI, BUF, F344 and MR haplotypes, and 
increases with BN (Figure 7D).  
 
Within the body weight QTL, there are only 11 genes, nine of which are pseudogenes or 
uncharacterized LOC proteins, leaving only Ccser1 and Grid2 (Figure 7C, Table S3).  None of 
the genes at this locus contained highly conserved potentially damaging non-synonymous 
variants.  Both Ccser1 and  LOC108350839 are expressed in liver, but neither’s expression was 
significantly associated with the body weight QTL, ruling these out as candidate mediators.  The 
brain-specific Grid2 is the only gene that has previously been linked to body weight [27] and 
Grid1 was recently associated with BMI in human GWAS [5], implicating Grid2 as the most 
likely candidate at this locus.  
 
Discussion 
This is the first study to map adiposity traits genome-wide using HS rats and demonstrates their 
utility for uncovering genes and variants likely to impact human adiposity.  We identified QTL 
for RetroFat on rat chromosomes 1 and 6 and a QTL for body weight on chromosome 4.  Using 
various fine-mapping procedures, we identified three likely candidate genes within the 
chromosome 6 RetroFat locus: a protein-coding variant within Adcy3, and transcriptional 
regulation of Krtcap3 and Slc30a3 that mediate between the QTL and RetroFat. Within the 
chromosome 1 RetroFat QTL, we identified a variant within Prlhr that increases fat pad weight.  
Lastly, Grid2 was identified as the most likely candidate gene within the body weight locus.  It is 
of interest that several of these candidate genes play a role in neural regulation of energy 
metabolism and/or feeding behavior. 
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As expected, both the HS founders and the HS population varied for adiposity traits, with BUF 
showing the highest adiposity and ACI, BN and M520 showing the lowest. As seen in humans 
[3, 4], these traits were highly heritable.  Also similar to humans [2], increased body weight, 
particularly visceral fat pad weight (RetroFat and EpiFat), was significantly associated with 
several measures of metabolic health in the HS rats, indicating that genes underlying QTL for 
adiposity traits are likely to contribute to overall metabolic health in HS rats.   
 
Despite high heritability for adiposity traits in this model, we found only three QTL for the five 
traits that were studied.  The remaining heritability could be attributable to loci of small effect 
and/or complex genetic architecture that lie below the limit of detection in this study, and this 
accords with the fact that the QTL we identified were each of relatively large effect (12.33%, 
13.33% and 11.05% respectively). The identified QTL also had relatively small LD support 
intervals (3.35 Mb, 1.19 Mb and 6.14 Mb, respectively), significantly decreasing the number of 
potential candidate genes within each QTL relative to traditional QTL studies using F2 intercross 
or backcross animals; the map density, however, was too low for high resolution mapping of the 
genes within the interval. We expect that increasing both the number of animals used as well as 
the density of genotyping would serve to uncover additional loci.   
 
The chromosome 6 RetroFat locus encompassed 6.14 Mb, contained 130 genes and was driven 
by the WKY haplotype.  Using a fine-mapping procedure that allowed for the presence of 
multiple signals, we identified a 1.46 Mb plausible region for the QTL.  Adcy3 was the only gene 
in this region to contain a highly conserved, non-synonymous variant in the WKY founder strain 
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that is predicted to be damaging: the leucine-to-proline switch at amino acid 121 would likely 
induce a bend in the helix leading to altered membrane interactions and binding.  In addition, we 
found that multiple genes within the locus map as eQTL.  Subsequent mediation analysis 
supported roles for Krtcap3 and Slc30a3, with Krtcap3 expression presenting as a full mediator 
of the QTL and Slc30a3 expression as a partial/suppressor mediator. Although little is known 
about Krtcap3, Slc30a3 is a zinc transporter that plays a role in glucose transport and metabolism 
[28], and Adcy3 is an enzyme that catalyzes the cAMP second messenger system and is likely 
involved in energy homeostasis [29].  The POMC/RBJ/ADCY3 region has previously been 
identified in multiple human GWAS for BMI and obesity [8, 30-32].  Interestingly, a non-
synonymous amino acid change (Ser107Pro) in the human Adcy3 gene [8], which falls within the 
same transmembrane helix as the rat variant, has been identified as the causal variant in height-
adjusted childhood BMI [31], indicating the same likely causal variant between rat and human.  
Adcy3 knock-out and haplo-insufficient mice become obese with age, exhibiting increased food 
intake and decreased locomotion [33, 34].  In addition, gain of function in Adcy3 protects against 
diet-induced obesity [35], further supporting a causal role for this gene.   
 
The chromosome 1 RetroFat locus encompassed 1.19 Mb, contained 15 genes, with BUF, MR, 
and WKY haplotypes increasing RetroFat.  Prlhr, containing a non-synonymous variant in both 
the BUF and WKY strains, stood out as the most likely candidate gene: the variant fell within the 
methionine start site and leads to removal of the conserved N-terminal region and half of 
transmembrane helix 1, likely having a large impact on protein function.  This variant is found in 
several other rat strains including FHH, GK, LEW and SD.  Prlhr is known to play a role in 
feeding behavior, with ICV administration in the hypothalamus leading to decreased food intake 
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[36], and Prlhr knock-out mice exhibiting increased food intake, body weight and fat pad weight 
[37].   Interestingly, this specific variant did not alter feeding behavior in outbred Sprague-
Dawley rats [38], indicating that the effect of the variant on fat pad weight may be independent 
of food intake, although additional studies are needed to confirm this. 
 
The body weight locus encompassed 3.35 Mb and contained 11 genes, none of which contained 
highly conserved non-synonymous variants predicted to be damaging between the two haplotype 
effect groups: ACI, BUR, F344, MR versus BN.  Only one gene in the region, Grid2, has 
previously been linked to obesity, jointly with tobacco use, in a family-based study [27], making 
it the most likely candidate gene.  Interestingly, Grid1 was associated with BMI in a recent 
human GWAS [5], further supporting a potentially causal role for Grid2 within the rat body 
weight locus. Grid2 encodes the glutamate ionotropic receptor delta type subunit 2 and is known 
to play a role in synapse formation, particularly within the cerebellum [39].  Synaptic formation 
and plasticity are increasingly being recognized as playing a role in metabolism and energy 
balance [40].  Additional work, including assessing Grid2 expression levels in brain, is needed to 
confirm or eliminate Grid2 as the causal gene at this locus.  
 
In summary, we have used HS rats to identify QTL for adiposity traits, leading to identification 
of five candidate genes and two likely causal variants.  Some genes have previously been 
identified in human GWAS or linkage studies (Adcy3, Grid2) or implicated in rodent models of 
obesity (Adcy3, Prlhr), while two genes are novel (Krtcap3, Slc30a3).   The Adcy3 variant falls 
within the same transmembrane helix as that found in humans indicating direct human relevance 
of this work.   It is also of interest that Adcy3, Prlhr and Grid2 have previously been found to 
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impact feeding behavior and/or neural regulation of metabolism.  This work demonstrates the 
power of HS rats for genetic fine-mapping and identification of underlying candidate genes and 
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Spearman’s rank correlation with Bonferonni-adjusted p-values in parentheses (bold if <0.05). To mitigate 
potentially confounding effects of experimental covariates, correlations are performed on phenotypic residuals (ie, 
on the residuals after regressing out covariate effects from the rank-inverse normal transformed phenotype). 
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Figure Legends  
Figure 1: Adiposity traits in inbred founders and HS rats.  Mean + SD are shown.  BMI is body 
mass index from nose to end of tail (BMI_Tail_End) and from nose to base of the tail 
(BMI_Tail_Base).  EpiFat and RetroFat are epididymal and retroperitoneal fat pad weight, 
respectively.  Gray circles represent individual animals from 8-19 individuals from 6 of the 
founder strains, and the HS rats (989 in body weight; 741 in RetroFat, EpiFat, and 
BMI_Tail_End; and 740 in BMI_Tail_Base).  See text for statistical differences between founder 
strains.   
 
Figure 2.  Significant correlations between RetroFat (retroperitoneal fat pad weight) and A) 
fasting insulin (p = 4.75e-27), B) fasting total cholesterol (p = 1.02e-20) and C) fasting 
triglycerides (p = 2.55e-20) in HS rats.  Plots show the residuals of rank-inverse normal 
transformed phenotypes with nuisance factors regressed out to restrict correlation estimates to 
that between RetroFat and these metabolic traits.  Significant correlations were also found 
between RetroFat and several other measures of metabolic health (see Table 1). 
 
Figure 3. A) Genome scan of RetroFat.  X-axis is position on chromosome and y-axis is the –
logP level of association.  Genome-wide significance thresholds were calculated using 
parametric bootstraps from the null model (𝛼 = 0.1, logP = 4.70). B)  The grey region highlights 
the 6.14 LD support interval of the chromosome 6 QTL showing neighboring markers that are 
correlated with the peak marker, representing genomic regions likely to contain the causal 
variant underlying the statistical signal.  C) Annotation of genes that fall within the support 
interval.  The entire 6.14 region is shaded in grey, with the fine-mapped 1.46 Mb region shaded 
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in dark grey.  Only genes that have a cis eQTL are shown.  All 130 genes within the region are 
listed in Supplementary Table S1.  D) Additive haplotype effects were estimated using the 
Diploffect model, which takes into account uncertainty in haplotype state. SNP allele 
information is overlaid on the haplotype effects, and are distinguished by black or gray. The 
WKY haplotype, the only haplotype with the C allele at the chromosome 6 locus, has a 
significantly negative effect on phenotype.  E) Protein modeling for ADCY3.  Variant L121P of 
ADCY3 is found with the conserved hydrophobic core of the transmembrane helices.  A zoomed 
in view is shown to the right.  The middle panel shows sequence alignments of amino acids. 
ADCY3 amino acid 121 is also 100% conserved (red) as a leucine in 86 analyzed vertebrate 
species. A human SNP is known at amino acid 107 (yellow). Using the DNA information from 
the 86 nucleotide sequences for ADCY3, there is also evidence of selective pressure in the DNA 
sequence to conserve the amino acid.  Bottom panel shows molecular dynamic simulations for 
ADCY3. Simulations performed on the protein dimer for wild type (WT blue) or the mutant 
(ADCY3 L121P, red) suggests that the models’ average movement over time is altered.  Altered 
movement is seen in the simulations for ADCY3 with fluctuation of amino acids found near 
amino acid 121 when mutated.    
 
Figure 4.  Mediation analysis identified the expression levels of six genes (Wdr43, Ppp1cb, 
Gpn1, Krtcap3, Slc30a3, and Atraid; Table S5) in the RetroFat chromosome 6 QTL interval as 
potential mediators of the QTL effect on the phenotype. [Middle column] Comparisons of the 
RetroFat chromosome 6 association scan with association scans for the potential mediators 
reveals them to likely have co-localizing cis eQTL with the RetroFat QTL. [Left column] The 
haplotype effects on RetroFat at the QTL and on the mediators at the eQTL reveals that in this 
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region, the WKY haplotype is largely driving the differences in RetroFat and mediator gene 
expression, suggesting a possible connection between RetroFat and local gene expression. [Right 
column] RetroFat chromosome 6 association scans, conditioned on candidate gene expression, is 
consistent with the mediation analysis finding that Krtcap3 is a strong candidate as full mediator 
of the effect of QTL on RetroFat. When Krtcap3 expression is included in the model, the QTL is 
largely removed. Slc30a3, as a potential suppressor of the QTL effect on RetroFat, actually 
increases the significance seen at the QTL. 
 
Figure 5.  Model demonstrating role of Adcy3, Krtcap3 and Slc30a3 on RetroFat.  WKY 
haplotype increases expression of Krtcap3, which is itself negatively correlated with RetroFat 
(Figure S4), and thus the causal path is consistent with the negative WKY effect on RetroFat at 
the locus.  In contrast, WKY decreases expression of Slc30a3, which is also negatively 
correlated RetroFat, suggesting Slc30a3 is a suppressor of the QTL/Krtcap3 effect.  Finally, the 
non-synonymous variant with Adcy3 causes amino acid change L121P leading to lower RetroFat.  
 
Figure 6. A) Genome scan of RetroFat as described in Figure 3A.  B) The grey region highlights 
the 1.19 Mb LD support interval for the chromosome 1 locus representing neighboring markers 
that are correlated with the peak marker, representing genomic regions likely to contain the 
causal variant underlying the statistical signal.  C) Annotation of the five characterized genes that 
fall within the support interval.   D) Additive founder haplotype effects for the chromosome 1 
RetroFat locus. Additive haplotype effects were estimated using the Diploffect model, which 
takes into account uncertainty in haplotype state. SNP allele information is also overlaid on the 
haplotype effects. The C allele is shared by ACI, F344, and M520, that possesses a variant with a 
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negative effect on RetroFat, whereas BUF, MR and WKY haplotypes result in increased 
RetroFat at this locus.  E)  Protein modeling for PRLHR.  Variant M1I of PRLHR is found 
within the methionine start site.  The next start site is at position 65 leading to removal of the 
conserved N-terminal region and half of transmembrane helix 1.  16 amino acids removed are 
under selective pressure (middle panel) and the deletion of the first 64 amino acids causes a 
destabilization of the entire proteins dynamics as seen by the molecular dynamic simulations 
(bottom panel). 
 
Figure 7.  A) Genome scan of body weight.  X-axis is position on chromosome and y-axis is the 
–logP level of association.  Genome-wide significance thresholds were calculated using 
parametric bootstraps from the null model (significant:	𝛼 = 0.05, logP = 4.86) and conservative 𝛼 = 0.05 Bonferroni thresholds (logP = 5.16).   B) Linkage disequilibrium support interval in 
grey is 3.35 Mb. C)  Annotation of the two characterized genes that fall within the support 
interval.  D) Additive haplotype effects for chromosome 4 body weight QTL.  The C allele at the 
marker could represent shared haplotype descent between BN and M520, both which have an 
increasing effect on body weight at this locus. ACI, BUF, F344 and MR haplotypes have a 
decreasing effect of body weight at this locus, all of which share the A allele.  The WKY and 
WN also have an A allele and the WKY haplotype has an increasing effect on body weight, 
while the WN haplotype appears not to effect body weight, although the credible interval of both 
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